Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

This study will evaluate the safety and efficacy of MASCT-I combined with Doxorubicin and Ifosfamide for first-line treatment in patients with advanced soft tissue sarcoma.

Participants needed: 148
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: HRYZ Biotech Co.Updated: Jul 24, 2025Locations: 1
Eligibility criteria

Age≥18 years and≤70 years; [+9]

Previous treatment with targeted therapy, radiotherapy (radiotherapy to non-targ... [+20]

Read more
Status: Recruiting

HRYZ-T101 Injection for HPV18 Positive Solid Tumor

A multicenter, open label, single arm dose escalation phase I study to evaluate the safety, tolerability, and efficacy of HRYZ-T101 injection for HPV18 positive solid tumor. The study will investigate RP2D of HRYZ-T101 TCR-T cell injection.

Participants needed: 32
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: HRYZ Biotech Co.Updated: Feb 2, 2024Locations: 1
Eligibility criteria

1. The patient must be willing to sign the informed consent form. [+18]

1. Have a history of hypersensitivity to cyclophosphamide or fludarabine, and it... [+19]

Read more